Claude Maraoui is CEO & President at Journey Medical Corp (DERM). They have made 8 open-market trades across 1 company since 2023, most recently 2026-04-22.
CIK 0001893880
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $166K since 2023, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DERM | 2,435,990 | $12.1M |
Shares reported on the most recent Form 4, priced at the 2026-04-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DERM | SELL | 2025-05-02 | 2025-05-05 | $6.84 | $33K | +5.2% | +10.4% | +5.8% |
| DERM | SELL | 2025-03-11 | 2025-03-11 | $5.01 | $494K | +9.4% | +15.5% | +36.5% |
| DERM | SELL | 2025-03-06 | 2025-03-10 | $5.03 | $407K | +11.4% | +30.8% | +43.2% |
| DERM | SELL | 2025-03-03 | 2025-03-05 | $5.11 | $722K | +3.7% | +40.4% | +40.6% |
| DERM | BUY | 2024-03-22 | 2024-03-25 | $3.48 | $35K | +13.9% | +5.3% | +52.6% |
| DERM | BUY | 2023-09-06 | 2023-09-08 | $2.52 | $131K | -9.5% | -3.1% | +126.4% |
| DERM | SELL | 2023-07-24 | 2023-07-25 | $1.76 | $37K | +20.0% | +17.7% | +85.7% |
| DERM | SELL | 2023-05-16 | 2023-05-18 | $1.30 | $58K | +16.0% | +101.9% | +103.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.